LAP 07 was sponsored by Groupe Cooperateur Multidisciplinaire en Oncologie. Dr. Hammel reported honoraria from Roche.
Conference Coverage
Chemoimmunotherapy, chemoradiotherapy add no survival in pancreatic cancer
More GI Oncology News
- AI-Assisted Colonoscopy Linked to Higher Rate of Benign Lesion Removal
- Screening Options for Rare Malignancies
- Low-Volume Bowel Prep Easier, as Effective as Standard Prep in Hospitalized Patients
- GLP-1 RAs Reduce Early-Onset CRC Risk in Patients With Type 2 Diabetes
- AI Tool Helps Detect, Differentiate Pancreatic Lesions During Endoscopic Ultrasound
- FIT Completion and Yield Similar in Younger and Older Adults
- Value of AI-Aided Colonoscopy on Advanced Neoplasia Detection Unclear
- When It Comes to Polyp Diagnosis With CADx, Location Matters
Question 1 of 4